Key points are not available for this paper at this time.
Continuing improvement in the pharmacological and therapeutic properties of drugs is driving the revolution in novel drug delivery systems. In fact, a wide spectrum of therapeutic nanocarriers has been extensively investigated to address this emerging need. Accordingly, this article will review recent developments in the use of nanoparticles as drug delivery systems to treat a wide variety of diseases. Finally, we will introduce challenges and future nanotechnology strategies to overcome limitations in this field.
Building similarity graph...
Analyzing shared references across papers
Loading...
Nanomedicine
University of Florida
Eli Lilly (United States)
Hunan University
Add This Paper to Your Research Feed
Any time a new paper drops it will be there.
Bamrungsap et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: